http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006042246-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_749b3a1456063ddc4e519c228d4daac2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60a73fa1ee324c5bab115a910e1efe1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f986a38ee67780d6d3b93b0d99255174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_598ce4bd221334700e3c493de77fd58e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a0cfeaac1ec63665873a5bb752fa8df
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00375
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-18
filingDate 2005-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b42ea4c17becfc63cac97e4aa67adbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0adda2a5d053f43e01cde33c1fc3771
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fbc9c74ecd0368195c4cd9366bd6d38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_589626e72cee2c3317e3993113ae2743
publicationDate 2006-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006042246-A2
titleOfInvention Two-stage scar generation for treating atrial fibrillation
abstract The present invention seeks to provide an implant configured to utilize at least two different scar-generating mechanisms that are generated in sequential or overlapping stages. For example, in one embodiment the present invention provides an expandable device that can be positioned at a desired target location within a patient to generate mechanical ablation damage. After a predetermined amount of mechanical ablation has occurred, additional ablation damage is generated by a different source, such as energy delivery, drug delivery, or inflammatory material delivery. In this respect, the overall ablation scarring can be better controlled by utilizing the ablation techniques that are most appropriate at specific phases of a technique or locations within a patient.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8409268-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9295484-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007128818-A1
priorityDate 2004-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003055491-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401586
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25043
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2006
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128834080
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396360
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ99372
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID103183906
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226503711
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127750960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5746
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395836
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13717
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129410028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13342
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP54320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448908333
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5248
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11547

Total number of triples: 72.